Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-FR
Language French French
Date Updated 2017-03-14 2017-03-13
Drug Identification Number 00828564 00828564
Brand name TEVA-RANITIDINE TEVA-RANITIDINE
Common or Proper name RANITIDINE RANITIDINE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients RANITIDINE RANITIDINE
Strength(s) 150MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 60
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-07-16 2016-07-16
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments